Menu

Theranos CEO Presents New Device

The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.

Aug 2, 2016
Kerry Grens

FLICKR, STEVE JURVETSONBlood-testing company Theranos, which has been in hot water with federal regulators after selling tests to consumers that were not accurate, is trying to get back in the game. While CEO Elizabeth Holmes has been banned from operating a lab for two years, she presented her firm’s latest technology yesterday (August 1) at the American Association for Clinical Chemistry (AACC) conference—to what appears to have been a rather unimpressed crowd.

“Regarding Theranos’ broad claims of being able to run 70-plus tests on a single drop of blood, AACC [panel/session] moderator Stephen Master told Holmes, ‘The evidence you presented fell far short of that,’” Business Insider reported. “The comment was met with applause from the audience.”

Theranos has been criticized for its secrecy, not publishing data in peer-reviewed journals or presenting at scientific conferences. Although Holmes’s presence yesterday seemed like a step in direction of transparency, “the technology she described, however, roughly echoed the unproven breakthroughs previously claimed by the company,” MIT Technology Review reported.

Holmes debuted Theranos’s so-called miniLab, which she said will someday be able to run 160 different assays, from lipid panels to Zika tests, according to STAT News. If the machine can accomplish what Holmes claims, it would be an impressive device. “I’ve never seen anybody put this much stuff in a box,” Danyel Tacker, an associate professor of pathology at West Virginia University, told STAT.

While Holmes offered up data from within Theranos, she did not present any externally validated results to the packed room. “In my mind, Theranos shouldn’t get to trade on the publicity they’ve gotten for the trouble they’ve had,” Master told Wired, “and then get to say to everybody, ‘Oh, and you guys have to pretend we are starting from scratch.’”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening